425: Aegon Reports Robust H1 2026 Results, Boosts Share Buyback

Aegon Ltd. announced strong first-half 2026 financial and commercial results, including a significant increase in operating result and capital generation, alongside an enhanced share buyback program and dividend.

Summary

• Aegon reported a robust first half of 2026 with an operating result of EUR 804 million, an 9% increase compared to 1H 2025, driven by strong commercial momentum and favorable market conditions.
• Operating capital generation (OCG) increased by 27% to EUR 416 million, attributed to strong business growth and improved claims experience.
• The company demonstrated strong commercial performance across its segments, including a 54% rise in US new individual life sales and significant growth in Retirement Plans and Asset Management net inflows.
• Aegon's capital position remains strong, with EUR 1.7 billion in Cash Capital at Holding, supported by EUR 392 million in free cash flow and the completion of a EUR 227 million share buyback in 1H 2026.
• The ongoing share buyback program is being increased by EUR 150 million to a total of EUR 350 million for the second half of 2026.
• An interim dividend of EUR 0.21 per common share was announced, an 11% increase compared to 1H 2025.
• Progress is being made on the redomiciliation to the US, with key milestones including the sale of Aegon UK and an agreement with Vereniging Aegon on future US governance.
• The company is on track to deliver its financial ambitions for 2026 and 2027, targeting growth in operating result, OCG, and free cash flow.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive filing, with strong financial results, increased capital generation, and a clear strategic direction, including a significant share buyback and dividend increase.

Positives

• Operating result increased by 9% to EUR 804 million in 1H 2026, reflecting strong commercial momentum and favorable markets.
• Operating capital generation (OCG) surged by 27% to EUR 416 million, driven by business growth and improved claims experience.
• US new individual life sales increased by 54%, and indexed annuities grew by 17%.
• Retirement Plans saw strong written sales, and Asset Management experienced net inflows.
• Cash Capital at Holding reached EUR 1.7 billion, with EUR 392 million in free cash flow generated in 1H 2026.
• The share buyback program is being increased by EUR 150 million to EUR 350 million for 2H 2026.
• The interim dividend per common share is up 11% to EUR 0.21.
• Global Platforms operating margin improved by 4.7 percentage points to 20.2%.

Negatives

• Free cash flow decreased by 11% to EUR 392 million in 1H 2026 compared to 1H 2025.
• Group solvency ratio decreased by 15 percentage points to 169%.
• Net profit was on the same level as 1H 2025, with higher operating results offset by lower non-operating items and higher other charges.
• EUR 294 million in charges were booked for US assumption updates related to policyholder behavior and lower mortality improvement.
• EUR 137 million in expenses were booked for redomiciliation and US GAAP implementation.
• International OCG was impacted by EUR 20 million of unfavorable items in 1H 2026.
• China's new life sales were lower due to repricing reflecting the current economic environment.
• Spain & Portugal experienced unfavorable claims experience due to storms.

Risks

• Changes in general economic and/or governmental conditions, particularly in key operating regions.
• Performance of financial markets, including frequency and severity of defaults, corporate bankruptcies, and volatility in credit, equity, and interest rates.
• Changes in insurer financial strength ratings and their impact on written premium, policy retention, profitability, and liquidity.
• Applicable solvency requirements (Bermuda, EU Solvency II, US) affecting capital maintenance and dividend payments.
• Changes affecting interest rate levels, currency exchange rates (particularly EUR/USD and EUR/GBP), and global inflation.
• Increasing levels of competition in key markets.
• Potential for litigation or regulatory action requiring significant damages or business changes.
• Risks associated with the proposed redomiciliation, including potential delays, failure to realize benefits, and impact on personnel and operations.

Future Outlook

Aegon is on track to deliver its financial ambitions for 2026 and 2027, which include growing the 2025 run-rate free cash flow by around 5% per annum, increasing the dividend per share by more than 5% per annum, growing the 2025 run-rate operating result by around 5% per annum, and growing the 2025 run-rate OCG by 0%-5% per annum. The company anticipates continued growth in strategic assets and stable financial assets, with a self-funded growth strategy and reinvestment in new business opportunities.

Management Comments

• "Robust commercial and financial results reflecting strong commercial momentum and favorable markets."
• "Strong commercial performance demonstrated by 54% increase in US new individual life sales, more than 100,000 WFG agents, strong written sales in Retirement Plans, and net inflows in Asset Management."
• "Strong capital positions and confidence in the business outlook."
• "Increasing the ongoing share buyback program by EUR 150 million to a total of EUR 350 million in 2H 2026."
• "Moving at pace with the redomiciliation with a number of milestones including the sale of Aegon UK to Standard Life and the agreement with Vereniging Aegon on future US governance."

Industry Context

StockSavvy.ai notes that Aegon's performance aligns with a broader trend of insurers focusing on core markets and streamlining operations. The redomiciliation to the US is a significant strategic move to align with its largest market and potentially attract US investors. The increased focus on capital generation and shareholder returns through buybacks and dividends is also consistent with industry practices aimed at enhancing shareholder value.

Management Changes

Corporate Governance

Related Party Transactions

• Agreement with Vereniging Aegon on future US governance, including conversion of shares and establishment of Stichting Aegon Fonds Nederland.
• Sale of Aegon UK to Standard Life.

Stakeholder Impact

• Shareholders: Increased interim dividend and expanded share buyback program signal positive returns. Redomiciliation to the US may improve access for US investors.
• Employees: Implementation of a strengthened leadership structure and transition plans for head-office functions.
• Regulators: Redomiciliation will lead to reassessment of group supervision scope and alignment with US insurance supervision.
• Vereniging Aegon: Agreement on future US governance framework, including conversion of voting rights and establishment of a new Dutch foundation.

Next Steps

• Complete the redomiciliation to the US, including the transition of the legal seat and renaming to Transamerica Inc.
• Implement head-office transition plans, gradually building the head-office set-up and processes until the end of 2027.
• Begin dry runs for US GAAP implementation in 2H 2026, with full US GAAP reporting starting from FY 2027.
• Hold an Extraordinary General Meeting (EGM) on October 8, 2026, for approval of relocation and constitutional document amendments.
• Continue the share buyback program, aiming to complete the increased EUR 350 million program by the end of 2026.
• Prepare for the first US GAAP reporting in February 2028, including SEC 10-K filing.

Key Dates

Recommendation

The filing presents strong operational and financial results, with increased capital generation and shareholder returns. However, the significant costs and complexities associated with the redomiciliation to the US, along with potential risks outlined in the filing, warrant a cautious approach. While the outlook is positive, the execution of the strategic transformation and integration into the US market requires close monitoring. Therefore, a 'hold' recommendation is appropriate, balancing the positive performance with the inherent uncertainties of major strategic shifts.

Keywords

Aegon, Financial Results, Operating Result, Capital Generation, Share Buyback, Dividend, Redomiciliation, US GAAP